OKYO Pharma

OKYONasdaq Guernsey Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$50.422 M

$1.49 -2.93%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

52,479,527

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#125MiNK TherapeuticsINKT$54.6M
#126TScan TherapeuticsTCRX$52.0M
#127OKYO PharmaOKYO$50.4M
#128Instil BioTIL$50.3M
#129Atyr PharmaATYR$50.1M

Where these numbers come from

Share counts and financials for OKYO Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.